Clinical trial Recruiting at 1 site Interventional Ages 18 to 55

Effects of isocapnic respiratory endurance training in healthy adults

Official title: The Effects of Isocapnic Respiratory Muscle Endurance Training on the Multidimensional Components and Neurophysiological Mechanisms of Exertional Breathlessness in Healthy Adults

Run by University of British Columbia · NCT07103291 · Data updated 2026-11-12

This study tests whether 5 weeks of isocapnic hyperpnea respiratory muscle training using the BreathWayBetter device can reduce breathlessness and improve peak exercise performance in competitive cyclists and other healthy adults.

More Healthy Older Adults trials

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment32 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedAugust 4, 2025
Main results expectedAugust 1, 2026
Study endsAugust 1, 2026
Registry record updatedMay 15, 2026
Trial IDNCT07103291 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults 18–55 who are competitive cyclists or triathletes with normal lung function and access to a compatible digital device.

Probably not a fit

Individuals with significant cardiopulmonary disease or current heavy nicotine/cannabis use, or those unable to perform exercise tests, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy adults who regularly train at high levels will perform 5 weeks of voluntary isocapnic hyperpnea training with the BreathWayBetter device or a sham version. The study will measure changes in the intensity and unpleasantness of dyspnea during exercise, as well as peak oxygen uptake (VO2peak) from pre- to post-training. Researchers will also explore how changes in performance relate to changes in perceived breathlessness. The trial aims to help tailor respiratory muscle training for athletes and could inform broader use in clinical populations if effective.

Why it matters

Potential benefit: If successful, participants may experience less breathlessness during exercise and improved endurance performance.

How similar studies have gone: Previous work on inspiratory muscle training is established, but this specific isocapnic hyperpnea approach is less well-studied, making the evidence more exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-55 years of age (inclusive)
* Male or Female (biological sex)
* Body mass index greater than 18 or less than 30 kg/m2
* Normal pulmonary function: FEV1/FVC \> 0.70 and FEV1 ≥ 80%
* Able to read and understand English
* Regularly trains and/or competes at a regional, national, or international level as a road cyclist or triathlete
* Access to a device with the capability to download the Isocapnic app (Apple IOS or Google Play/Android) or the ability to use the Web Based application.

Exclusion Criteria:

* Currently smoke, vape, or use cannabis, or have a history of frequent smoking, vaping or cannabis use
* History of, or current symptoms of cardiopulmonary (i.e., lung and/or heart) disease (excluding controlled asthma)
* Heart problem; a serious infection within the body; a neuromuscular (nerve to muscle) or musculoskeletal (muscle, ligament and/or bone) disorder; or other health problem that will be made worse with exercise testing
* Contraindications to exercise testing defined as anything that would prevent exercise under proper and safe conditions (e.g. a problem with the heart or lungs, muscle or bone injury, a serious infection)
* Currently pregnant
* Required to read and understand English due to the nature of the consent form and study materials, including questionnaires and training instructions, which are only available in English.

Where it's running

  • St. Paul's Hospital
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.